![]() |
| Allyson Schwartz |
Former Congresswoman Allyson Schwartz has signed on as senior advisor at FTI Consulting's strategic communications unit. She will counsel clients on healthcare policy and how to navigate the regulatory thicket.
The Pennsylvania Democrat served on the Ways and Means and Budget Committees during her 10-year stint on Capitol Hill.
Schwartz, who was commissioner of Philadelphia's Dept. of Health, led the Congressional push to reform the doctor payment system and promoted primary care and integrated care delivery.
Most recently, she was CEO of the Better Medicare Alliance lobbying group.
Charlene MacDonald, America's healthcare & life sciences head in the stratcomm unit, said Schwartz's decades of experiences in local, state and federal government will prove invaluable to FTI's clients.


Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice.
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.



